Cost-Effectiveness Thresholds: the Past, the Present and the Future

被引:0
|
作者
Praveen Thokala
Jessica Ochalek
Ashley A. Leech
Thaison Tong
机构
[1] University of Sheffield,Health Economics and Decision Science, School of Health and Related Research
[2] University of York,Centre for Health Economics
[3] Center for the Evaluation of Value and Risk in Health (CEVR),undefined
[4] Tufts Medical Center,undefined
来源
PharmacoEconomics | 2018年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cost-effectiveness (CE) thresholds are being discussed more frequently and there have been many new developments in this area; however, there is a lack of understanding about what thresholds mean and their implications. This paper provides an overview of the CE threshold literature. First, the meaning of a CE threshold and the key assumptions involved (perfect divisibility, marginal increments in budget, etc.) are highlighted using a hypothetical example, and the use of historic/heuristic estimates of the threshold is noted along with their limitations. Recent endeavours to estimate the empirical value of the thresholds, both from the supply side and the demand side, are then presented. The impact on CE thresholds of future directions for the field, such as thresholds across sectors and the incorporation of multiple criteria beyond quality-adjusted life-years as a measure of ‘value’, are highlighted. Finally, a number of common issues and misconceptions associated with CE thresholds are addressed.
引用
收藏
页码:509 / 522
页数:13
相关论文
共 50 条
  • [31] A RECENT ADOPTION OF COST-EFFECTIVENESS THRESHOLDS IN BRAZIL AND ITS REPERCUSSIONS
    Menezes, F.
    Sarmento, T. T. R.
    Oliveira, W. A.
    Sallum, F.
    VALUE IN HEALTH, 2024, 27 (06) : S139 - S139
  • [32] Cost-effectiveness thresholds and the Brazilian Unified National Health System
    De Soarez, Patricia Coelho
    Dutilh Novaes, Hillegonda Maria
    CADERNOS DE SAUDE PUBLICA, 2017, 33 (04):
  • [33] SHOULDN'T NICE COST-EFFECTIVENESS THRESHOLDS BE CHANGING WITH THE TIMES?
    Boodhna, T.
    Hendrich, J.
    VALUE IN HEALTH, 2017, 20 (09) : A704 - A704
  • [34] Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective
    Remme, Michelle
    Martinez-Alvarez, Melisa
    Vassall, Anna
    VALUE IN HEALTH, 2017, 20 (04) : 699 - 704
  • [35] Future drug prices and cost-effectiveness analyses
    Hoyle, Martin
    PHARMACOECONOMICS, 2008, 26 (07) : 589 - 602
  • [36] ANTICIPATED FUTURE DIRECTIONS IN COST-EFFECTIVENESS ANALYSIS
    BLUMSTEIN, A
    OPERATIONS RESEARCH, 1975, 23 : B263 - B263
  • [37] Future Drug Prices and Cost-Effectiveness Analyses
    Martin Hoyle
    PharmacoEconomics, 2008, 26 : 589 - 602
  • [38] Cost-Effectiveness and Future Implications for Cardiovascular Imaging
    Shaw, Leslee J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (03) : 350 - 357
  • [39] Estimating the cost of blood: past, present, and future directions
    Shander, Aryeh
    Hofmann, Axel
    Gombotz, Hans
    Theusinger, Oliver M.
    Spahn, Donat R.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2007, 21 (02) : 271 - 289
  • [40] Transaction cost analysis: Past, present, and future applications
    Rindfleisch, A
    Heide, JB
    JOURNAL OF MARKETING, 1997, 61 (04) : 30 - 54